Coronavirus: Vaccination
The question
To ask the Secretary of State for Health and Social Care, whether his Department will consider allowing families of vulnerable patients who are at highest risk, particularly those affected by transplants and kidney disease, access to NHS COVID vaccinations.
Answered by Ashley Dalton
The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.
The JCVI has advised that population immunity to COVID-19 has increased due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.
The JCVI has also advised that as currently available COVID-19 vaccines provide limited protection against transmission and mild or asymptomatic disease, the focus of the programme is on offering vaccination to those most likely to directly benefit from vaccination. These are the oldest adults and individuals who are immunosuppressed.
The Government has accepted the JCVI advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:
- adults aged 75 years old and over;
- residents in care homes for older adults; and
- individuals aged six months and over who are immunosuppressed.
As for all vaccines, the JCVI keeps the evidence under regular review.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →